Court: Scientist’s Emails Are Private

Judges rule that climate scientist Michael Mann’s communications are not subject to Freedom of Information Act requests.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Michael Mann testifying before Congress, with National Academy of Science Chair Ralph Cicerone (July 27, 2006)NATIONAL ACADEMY OF SCIENCESA punching bag of climate change skeptics, Michael Mann has seen his fair share of intrusion into his e-mails. In 2009, he was one of a number of scientists whose hacked messages were part of the “Climategate” scandal. But a judge in Virginia ruled last week (April 17) that Mann’s e-mails from his time as a professor at the University of Virginia cannot be obtained through a Freedom of Information Act (FOIA) request.

“This is a victory for science, public university faculty, and academic freedom,” Mann, who is now a professor at Penn State, said in a statement. The latest decision upheld a lower court’s ruling.

The American Tradition Institute (ATI), now called the Energy & Environment Legal Institute, had sued to obtain Mann’s emails from the University of Virginia (UVA). Justice Donald Lemons wrote in the court’s decision that handing over the e-mails would have put the school at a “competitive disadvantage,” thereby allowing it an exemption from FOIA. “In the context of the higher education research exclusion, competitive disadvantage implicates not only financial injury, but also harm to university-wide research efforts, damage to faculty recruitment and retention, undermining of faculty expectations of privacy and confidentiality, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies